Literature DB >> 25119599

miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.

Ronglin Zhai1, Xuefeng Kan, Bo Wang, Hansong Du, Yueping Long, Heshui Wu, Kaixiong Tao, Guobin Wang, Lihong Bao, Fen Li, Wanli Zhang.   

Abstract

We aimed to study the post-translational regulation of CD151 by the microRNA miR-152. CD151 is highly expressed in gastric cancer (GC) and has been shown to accelerate GC by enhancing invasion and metastasis; however, its regulation is still unclear. Our results showed decreased expression of miR-152 in GC tissue samples and cell lines. In addition, miR-152 complementation significantly inhibits both the proliferation and motility of GC cells. CD151 was found to be a target of miR-152, and overexpression of CD151 attenuated the suppressive effect of miR-152. Our findings highlight an essential role of miR-152 in the regulation of proliferation and motility of GC cells and suggest a potential application of miR-152 in GC treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119599     DOI: 10.1007/s13277-014-2471-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis.

Authors:  Rafal Sadej; Hanna Romanska; Dean Kavanagh; Gouri Baldwin; Takashi Takahashi; Neena Kalia; Fedor Berditchevski
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

2.  Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

Authors:  Jinfeng Huang; Yue Wang; Yingjun Guo; Shuhan Sun
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

Review 3.  Gastrointestinal tumors: metastasis and tetraspanins.

Authors:  M Zöller
Journal:  Z Gastroenterol       Date:  2006-07       Impact factor: 2.000

4.  Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

Authors:  Yue Chen; Yongxi Song; Zhenning Wang; Zhenyu Yue; Huimian Xu; Chengzhong Xing; Zhuangkai Liu
Journal:  J Gastrointest Surg       Date:  2010-04-27       Impact factor: 3.452

5.  MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE.

Authors:  Liang Chang; Fengjie Guo; Yudong Wang; Yalei Lv; Bingjie Huo; Long Wang; Wei Liu
Journal:  Pathol Oncol Res       Date:  2013-07-03       Impact factor: 3.201

6.  Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer.

Authors:  Yuan-Yu Wang; Zai-Yuan Ye; Zhong-Sheng Zhao; Hou-Quan Tao; Shu-Guang Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

7.  MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151.

Authors:  Zhi-Bo Han; Zhouxin Yang; Ying Chi; Lei Zhang; Youwei Wang; Yueru Ji; Jinhan Wang; Hui Zhao; Zhong Chao Han
Journal:  Cell Physiol Biochem       Date:  2013-06-04

Review 8.  Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.

Authors:  Koji Otani; Xiaoxing Li; Tetsuo Arakawa; Francis K L Chan; Jun Yu
Journal:  Expert Rev Mol Diagn       Date:  2013-06       Impact factor: 5.225

9.  Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.

Authors:  Junying Chen; Desheng Yao; Yue Li; Hong Chen; Chanjuan He; Nan Ding; Yan Lu; Tingyu Ou; Shan Zhao; Li Li; Fengyi Long
Journal:  Int J Mol Med       Date:  2013-06-21       Impact factor: 4.101

10.  Overexpression of CD151 predicts prognosis in patients with resected gastric cancer.

Authors:  Yue-Ming Yang; Zhong-Wei Zhang; Qing-Meng Liu; Yi-Feng Sun; Ji-Ren Yu; Wei-Xing Xu
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more
  23 in total

1.  Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer.

Authors:  Gang Chen; Yong Tang; Jiang-Hua Wu; Feng-Hua Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Long Non-coding RNAs in Gastric Cancer: A True Relationship or miR Chance?

Authors:  Konstantinos Mavridis
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 3.  Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.

Authors:  Blanca Ortiz-Quintero
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

4.  Long Noncoding RNA PVT1 Acts as a "Sponge" to Inhibit microRNA-152 in Gastric Cancer Cells.

Authors:  Ting Li; Xiang-Ling Meng; Wen-Qi Yang
Journal:  Dig Dis Sci       Date:  2017-03-03       Impact factor: 3.199

5.  Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.

Authors:  Hao Yu; Pei Xiang; Qi Pan; Yijiao Huang; Nanlan Xie; Weimin Zhu
Journal:  Tumour Biol       Date:  2016-03-28

6.  Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.

Authors:  Feng Wang; Houqun Ying; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  Tumour Biol       Date:  2015-11-03

7.  miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer.

Authors:  Xuexiang Liu; Jinwan Li; Fengxian Qin; Shengming Dai
Journal:  Oncol Lett       Date:  2016-04-28       Impact factor: 2.967

8.  MiR-152 regulates metastases of non-small cell lung cancer cells by targeting neuropilin-1.

Authors:  Ya-Jun Zhang; Xiao-Cun Liu; Jin Du; Yi-Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.

Authors:  Bo Li; Zhongshi Xie; Bai Li
Journal:  Tumour Biol       Date:  2016-01-28

10.  Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.

Authors:  Jingxuan Xu; Jian Wen; Shuangquan Li; Xian Shen; Tao You; Yingpeng Huang; Chongyong Xu; Yaping Zhao
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.